PCU Manual Phar and Cosumer Protection
-
Upload
pokin-sakarinkhul -
Category
Documents
-
view
229 -
download
0
Transcript of PCU Manual Phar and Cosumer Protection
-
8/12/2019 PCU Manual Phar and Cosumer Protection
1/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
2/156
9,750
2554
-
8/12/2019 PCU Manual Phar and Cosumer Protection
3/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
4/156
2 17 1.
1) 2)
. . 3) . . 4) . . 5)
6) 7) . . 8)
. . 9) 2. 1)
2) 3) . . 4) . . 5)
6) . . 7) :
8)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
5/156
1 1 1 1 1 () () () () ()1. 1. 1. 1. 1. 1.1 1.2 1.3 2. (Empowerment)2. (Empowerment)2. (Empowerment)2. (Empowerment)2. (Empowerment)2.1 2.2 3. (Risk management)3. (Risk management)3. (Risk management)3. (Risk management)3. (Risk management)3.1 (Risk assessment)3.2 (Risk management)3.3 (Risk Communication) 1. 2. ( .)
3. 4.
2 2 2 2 2
-
713
131414171718212223262929
3134
36
4159
85
-
8/12/2019 PCU Manual Phar and Cosumer Protection
6/156
1 : 2 :
3 :
4 :
5 :
6 :
7 :
8 : ( ) 9 : ( ) 10 : ( ) 11 : ( )
12 : ( )
/ 13 : ( )
(Empowerment ) 14 : 15 :
16 : 17 :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
7/156
()
-
8/12/2019 PCU Manual Phar and Cosumer Protection
8/156
2
-
8/12/2019 PCU Manual Phar and Cosumer Protection
9/156
3
(demand)
( )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
10/156
4
( . .)
( .)
5
1. 2. 3. 4. 5.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
11/156
5
3 . ( - -
) " "
" "
" "
1. 2. (Empowerment)3. (Risk
management)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
12/156
6
.
. .
( E m p o w e r m e n t )
( R i s k m a n a g e m e n t )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
13/156
1.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
14/156
8
-
8/12/2019 PCU Manual Phar and Cosumer Protection
15/156
9
3
1.
1.2. 3.
1.2.
1.11.11.11.11.1 1.1.1
-
-
8/12/2019 PCU Manual Phar and Cosumer Protection
16/156
10
- . .
-
1.1.2
1.1.3
1.21.21.21.21.21.2.1
1.2.2 (Base line data)
1.3 1.3 1.3 1.3 1.3 1.3.1
1.3.2
-
8/12/2019 PCU Manual Phar and Cosumer Protection
17/156
11
2.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
18/156
12
-
8/12/2019 PCU Manual Phar and Cosumer Protection
19/156
13
2
2.12.12.12.12.1 2.1.1
2. ( Empo we rme n t )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
20/156
14
( ) ( )
2.1.2
2.1.3
2.2 2.2 2.2 2.2 2.2
-
8/12/2019 PCU Manual Phar and Cosumer Protection
21/156
3. (Risk management)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
22/156
16
-
8/12/2019 PCU Manual Phar and Cosumer Protection
23/156
17
Model Risk Management Model
Model ( Model )
3.
( Ris k ma nageme n t )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
24/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
25/156
19
3.1.2 (Exposure assessment) ( 3.1.1)
3.1.3 (Risk characterization)
( 3.1.13.1.2)
3.2 (Risk Management)3.2 (Risk Management)3.2 (Risk Management)3.2 (Risk Management)3.2 (Risk Management)
3.1.1 ,3.1.2 3.1.3
3.2.1 (Risk minimization)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
26/156
20
(
)
/ / / / /
-
8/12/2019 PCU Manual Phar and Cosumer Protection
27/156
21
3.2.2
3.2.3 (Risk monitoring
and review)
3.2.4 (Policy)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
28/156
22
3.3 (Risk Communication)3.3 (Risk Communication)3.3 (Risk Communication)3.3 (Risk Communication)3.3 (Risk Communication)
,
1.
1.1 1.2 1.3
2. 2.1 /
2.2
3.
3.1 3.2
-
8/12/2019 PCU Manual Phar and Cosumer Protection
29/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
30/156
24
-
8/12/2019 PCU Manual Phar and Cosumer Protection
31/156
25
1.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
32/156
26
.
3 . ( - - )
" " " "
" "
-
8/12/2019 PCU Manual Phar and Cosumer Protection
33/156
27
. .
. .
(Best Practice)
( .)
2.
( . )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
34/156
28
. . 2546-2548 . ( .)
. . 2549 . " . .
2549-2551" " ( .)"
. . 2552 . . 2
1.
2.
3.
4.
3 1
-
8/12/2019 PCU Manual Phar and Cosumer Protection
35/156
29
2
3
.
.
( . .) .
. . -
( )-
( .)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
36/156
30
- .
-
- (
)
( .) .
" "
3.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
37/156
31
" "
2553 .
(
150,000 200 ) 2554
2553
-
8/12/2019 PCU Manual Phar and Cosumer Protection
38/156
32
"
"
4.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
39/156
33
(
) ( .) ( )
30
( )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
40/156
34
( .)
.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
41/156
5
-
8/12/2019 PCU Manual Phar and Cosumer Protection
42/156
36
-
8/12/2019 PCU Manual Phar and Cosumer Protection
43/156
37
( . .)
" "
1. " "
2. " " . .
. .
1. :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
44/156
38
. .
3. " " . .
( )4. " "
(Compliance)
(Inappropriate Prescribing)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
45/156
39
"
. . "
: ( )
( )
:
:
2.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
46/156
40
(Fee for Services)
3. - ( ) -
:
-
8/12/2019 PCU Manual Phar and Cosumer Protection
47/156
41
1.1.1.1.1. - - - - -
- Flunarizine, Kaolin pectin Erythromycin estolate ( http://www.haiap.org/objectives/rum/project-banned-drugs/)
- NOXY oxytetracycline NOXZY
Loperamide-
-
8/12/2019 PCU Manual Phar and Cosumer Protection
48/156
42
- Serratiopeptidase (
Dasen? Danzen? )
1
- - - - -
1.
. . 2510
2.
1Takeda Voluntarily Recalls its Anti-inflammatory Enzyme Preparation, Dasen? in Japan. (21 Feb
2011) http://www.takeda.com/press/article_40162.html
-
8/12/2019 PCU Manual Phar and Cosumer Protection
49/156
43
2 2551 http://www.thaifda.com/ed2547/?pg=result
3 . . .
2542. http://203.157.213.9/fda/system/system2.htm
16
10-24 2
3.
3
(Good health at low cost)
- 750
550 350
-
8/12/2019 PCU Manual Phar and Cosumer Protection
50/156
44
-
70:30
80:20 90:10
4.
( .).
4 Phenopthalein kaolin
pectin amoxicillin
2. - 2. - 2. - 2. - 2. - 1.
. . 2552 ( .)
960 94.14 5.86
(
-
8/12/2019 PCU Manual Phar and Cosumer Protection
51/156
45
- 2552
10
. )
2. antidote
3.
- - - - - 1.
" Good manufacturing
Practices, GMP" GMP
2.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
52/156
46
3. (CL) . . 2549
7
4.
.
3.3.3.3.3. - - - - -
. .
(Cold Chain) . 2552
9.9 90
-
8/12/2019 PCU Manual Phar and Cosumer Protection
53/156
47
- - - - -
Vendor ManagementInventory (VMI)
4. - 4. - 4. - 4. - 4. -
Superbug
-
8/12/2019 PCU Manual Phar and Cosumer Protection
54/156
48
E. Coli. - - - - -
(Clinical Practice Guidelines)
.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
55/156
49
4.
14 2554
.
(Pay for Peformance)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
56/156
50
/
-
8/12/2019 PCU Manual Phar and Cosumer Protection
57/156
51
-
8/12/2019 PCU Manual Phar and Cosumer Protection
58/156
52
1. .
2552. .: . 2553.
2. . . .
. . - .
-
8/12/2019 PCU Manual Phar and Cosumer Protection
59/156
6
-
8/12/2019 PCU Manual Phar and Cosumer Protection
60/156
54
-
8/12/2019 PCU Manual Phar and Cosumer Protection
61/156
55
1.
2. 3.
4.
- (Selection of drug)- (Procurement)- (Distribution)- (Utilization)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
62/156
56
( .)
" "
.
. .
. .
-
8/12/2019 PCU Manual Phar and Cosumer Protection
63/156
57
( .) .
----- .
1. 2. 3. 4.
. 1 01, 5.
6.
7. ()
-
8/12/2019 PCU Manual Phar and Cosumer Protection
64/156
58
8.
1. -
.
.
.
( ) . .
-
8/12/2019 PCU Manual Phar and Cosumer Protection
65/156
59
.
. .
.
1.
2.
3.
2.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
66/156
60
4.
5. .
1.
2.
3.
4.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
67/156
61
1.
1.1 3 .301(
.)1.2 1.3
1.4 1.5
1.1 - 1.4
2 -
1. .
2. .
-
8/12/2019 PCU Manual Phar and Cosumer Protection
68/156
62
1.
2.
.
2.
2.1 1 .301
(stock 0
) ( . 301 16.1)2.2
2.3 2.4
(
16.2)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
69/156
63
2.5 2.6 2.4,2.5
( )
2.7 2.8
2.1 -2.7
1.
2. 3.
4.
5.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
70/156
64
1.
2.
( 16.3)
3.
1. 2.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
71/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
72/156
66
2. : .
3. . 1 01 : , , ,
( )
. ( ) . 1 01
4. .301 :
.
5. / .: /
, , , , , , ,
6.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
73/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
74/156
68
: .
1.2
.
1.2.1 1. .301 :
2. :
3. . : 2( 1 1 ) ,
, ( + 1 2 )
4. (
16.4)1.2.2 .
-
8/12/2019 PCU Manual Phar and Cosumer Protection
75/156
69
1. .
2. .
3. -4.
,
.
: : : : :1. .
.301
/
2.
3. /
-
8/12/2019 PCU Manual Phar and Cosumer Protection
76/156
70
" "
4. .
5. . . / /
'
, ' , ' Stock card .301
6. . .
4.1 . 4.2 .
4
. 1 01 ,
-
8/12/2019 PCU Manual Phar and Cosumer Protection
77/156
71
.1 01 3.
1.1.1 . 3 .1 01
. 1. .2. 3. -
( )4. 5. 6. 7. 8. ( " ")
5. ( Expir ed dr ug) , ( Dead stock) , ( Over stock)
5.15.15.15.15.1
-
8/12/2019 PCU Manual Phar and Cosumer Protection
78/156
72
- 15 - 30
- 2-8
- Keep in Freezer - Cool Place - 5.25.25.25.25.2 - Pack
' , ' , '-
- 5- 3- 3- 3- 1
( Pre-pack) 1
1
-
8/12/2019 PCU Manual Phar and Cosumer Protection
79/156
73
- 8
-
.
5.35.35.35.35.3 (Dead stock) (Dead stock) (Dead stock) (Dead stock) (Dead stock)
1
.
5.45.45.45.45.4 (Over stock) (Over stock) (Over stock) (Over stock) (Over stock) Over stock
-
8/12/2019 PCU Manual Phar and Cosumer Protection
80/156
74
5.55.55.55.55.5
1 2
6.
1.
2. /
-
8/12/2019 PCU Manual Phar and Cosumer Protection
81/156
75
3. / / .4.
1.
2.
3. .
7. ( )
.
( ) . 2-8
( )
"
-
8/12/2019 PCU Manual Phar and Cosumer Protection
82/156
76
2554"
1. Stock
2.
15 .3. 4.
First expire in First expire out5. 56. Ice pack
7.
8. 2 - 89. 2
10.
11.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
83/156
77
. .
.
.
8.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
84/156
78
/
1
.
( 16.5)
( )
. 1-5 .
-
8/12/2019 PCU Manual Phar and Cosumer Protection
85/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
86/156
80
-
8/12/2019 PCU Manual Phar and Cosumer Protection
87/156
81
( .)
. .
.
(High Alert Drugs)
( )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
88/156
82
. (
) (
.
) 1 2 / 3 3
4
.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
89/156
83
1
1. - /OPD Card
2. 3.
4.
5.
, , , ,(DI) ,
6. -
(Medication error) - -
7.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
90/156
84
1. / 2. / -
, , , , ( )
3.
1. 2. / / 13.
2 /
3
1. , - , , , , ,
, ( , )
4
-
8/12/2019 PCU Manual Phar and Cosumer Protection
91/156
85
5 2
2.
3.
5.1 Identified 5.1 Identified 5.1 Identified 5.1 Identified 5.1 Identified 1. 2. " / "
5.2 5.2 5.2 5.2 5.2 (Prime Questions) (Prime Questions) (Prime Questions) (Prime Questions) (Prime Questions)
- /- /- - /-
-
- Exit care
- /
-
8/12/2019 PCU Manual Phar and Cosumer Protection
92/156
86
(Drug Counselling)(Drug Counselling)(Drug Counselling)(Drug Counselling)(Drug Counselling)
1.
2. 3.
4. 5. 6. 3
...
-
8/12/2019 PCU Manual Phar and Cosumer Protection
93/156
87
-
8/12/2019 PCU Manual Phar and Cosumer Protection
94/156
88
-
8/12/2019 PCU Manual Phar and Cosumer Protection
95/156
89
. . 2522
1. 1. 1. 1. 1.
2. 2. 2. 2. 2.
3. 3. 3. 3. 3.
1 :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
96/156
90
4. --4. --4. --4. --4. --
2
5. 5. 5. 5. 5.
. .2510
2 7
1. 2. 3. 4.
2 :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
97/156
91
5. 6. 7.
1-6 1- 4
1 - 4 ,6 7
-
1.1.1.1.1. - (.1) - (.1) - (.1) - (.1) - (.1)
( )
( 21)
- ( 39)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
98/156
92
(
)
2.2.2.2.2. - - - - - (.2) (.2) (.2) (.2) (.2)
(
)3.3.3.3.3. - - - - -
4.4.4.4.4. - - - - -
( )5.5.5.5.5. - (.) - (.) - (.) - (.) - (.)
(
)
3 4 3
1. 32. 3 4
-
8/12/2019 PCU Manual Phar and Cosumer Protection
99/156
93
( )
1. 2.
, . 2 ,
3 4 , - ,
3. 4.
5.
-
-
8/12/2019 PCU Manual Phar and Cosumer Protection
100/156
94
-- .. 2522-- .. 2522-- .. 2522-- .. 2522-- .. 2522 . .2522
----------
4
1. , , , , ,
2. ( )
, , , ,
3 :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
101/156
95
3. , ,
, , ,
4. 3 , , ,
-- -- -- -- -- 25
1.1.1.1.1. - -
-
- -
2.2.2.2.2. -
-
8/12/2019 PCU Manual Phar and Cosumer Protection
102/156
96
-
-
-
-
( 30
)3.3.3.3.3. - 4.4.4.4.4.
40 40 40 40 40
41 41 41 41 41
-
8/12/2019 PCU Manual Phar and Cosumer Protection
103/156
97
4 :
-- ..2535-- ..2535-- ..2535-- ..2535-- ..2535 . . 2535
-
8/12/2019 PCU Manual Phar and Cosumer Protection
104/156
98
" ."
""
1. -
( )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
105/156
99
2.
3.
1.1.1.1.1. (Irritation)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
106/156
100
2.2.2.2.2. (Allergy)
1.
2.
3.
4.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
107/156
101
5.
6. 7.
8. (AHAs ,Alpha
Hydroxy Acids)
24-48
-
8/12/2019 PCU Manual Phar and Cosumer Protection
108/156
102
1.
2.
( )
3. 4.
5. 6.
7. 8.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
109/156
103
1. , , ,
2. , , ,
, ,
5 :
- -
-
-
-
8/12/2019 PCU Manual Phar and Cosumer Protection
110/156
104
1.
- 40 . 120 .
- 10 .-
5 .-
-
- 12345678901 - 12345678901 - 12345678901 - 12345678901 - 12345678901
1. / 2. / 3. 4. 5. 6. 7. 8.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
111/156
105
2.
3.
4. 5.
6. 7.
-
. . 2541
- 31 59 10,000
-
8/12/2019 PCU Manual Phar and Cosumer Protection
112/156
106
-
-
- /
-
32(1)
32(2)
32(3)
35(1)
59
59
59
65
10,000
10,000
10,000
20,000
-
8/12/2019 PCU Manual Phar and Cosumer Protection
113/156
107
" " . .2542
; , ,
. .2522
1. . .2510 2. . .25223. . .2551
3 1. . .25352. . .2535
6 :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
114/156
108
2
1. . .2522
2. . .2518
2
1. . .2533
( )
2. . .2541 (
)3. . .25224. (
)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
115/156
109
1. 1. 1. 1. 1.
100%
2. 2. 2. 2. 2.
7 :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
116/156
110
3. ( )3. ( )3. ( )3. ( )3. ( )
MFG ......... (Manufacturing date) , EXP ......... (Expiry date)
2 39 , 2/1/39 ,2 JAN 96
4. 4. 4. 4. 4.
, , ,
5. -5. -5. -5. -5. -
( 5 . .......)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
117/156
111
6. 6. 6. 6. 6.
- . (
.)
- - , , , ( ) , ,
-
8/12/2019 PCU Manual Phar and Cosumer Protection
118/156
112
8 : ( )
( ) / /
-
8/12/2019 PCU Manual Phar and Cosumer Protection
119/156
113
9 : ( )
..................................................................
-
8/12/2019 PCU Manual Phar and Cosumer Protection
120/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
121/156
115
11 : ( )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
122/156
116
12 : ( )
/
-
8/12/2019 PCU Manual Phar and Cosumer Protection
123/156
117
13 : ( ) ( E mpowe r me nt )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
124/156
118
14 :
1. ( , ., . )
2.
3. BIO DIESEL4. BIO DIESELGLYCERIN 5. DVD BIO DIESEL6. DVD BIO DIESEL7. -8. DVD -9. DVD 10. 11. , ,
12.
13. 8
14.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
125/156
119
" "
3
1. 1. 1. 1. 1.
(Generic name)
15 :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
126/156
120
( . . . 2510)
( )
( . )
( Lot No.
) (Mfg Date Mfd.) ( Expiry Date
Exp. Date)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
127/156
121
2 . .
17 (
10- 25 )
-
8/12/2019 PCU Manual Phar and Cosumer Protection
128/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
129/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
130/156
124
.
2. 2. 2. 2. 2.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
131/156
125
/
/
1-2
(NSAIDs)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
132/156
126
1) 2)
3)
4)
1)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
133/156
127
2)
3)
4)
3. 3. 3. 3. 3.
-
3.13.13.13.13.1
-
8/12/2019 PCU Manual Phar and Cosumer Protection
134/156
128
Reye's syndrome
1 2550
1.
18 2.
3. 4. 5. 6.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
135/156
129
3.2 (Antidiarrhoeal combin3.2 (Antidiarrhoeal combin3.2 (Antidiarrhoeal combin3.2 (Antidiarrhoeal combin3.2 (Antidiarrhoeal combin
- 2552
1. Diiodohydroxyquinoline (
, )
Optic atrophy
2. Furazolidone (50 mg) (Anemia)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
136/156
130
1 Glucose-6-phosphatedehydrogenase deficiency (G6PD) Furazolidone
3. Neomycin sulfate (50 mg equivalent to Neomycinbase 35 mg) (Ototoxicity)
, , (Nephrotoxicity) (Malabsorption syndrome)
4. Phthalylsulfathiazole (250 mg)
Pseudomembranous colitis Kernicterus Toxic epidermal necrolysis Stevens-
Johnson syndrome Anaphylaxis
5. Light kaolin (250 mg) ( ,, ,
)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
137/156
131
3.3 3.3 3.3 3.3 3.3
2552
" " ( )
1. Methylene blue
-
8/12/2019 PCU Manual Phar and Cosumer Protection
138/156
132
2. Potassium nitrate (methaemoglobinemia)
(carcinogenicity)3. Hexamine
(hematuria) formaldehyde
4. 4. 4. 4. 4. : : : : :
4.14.14.14.14.1 ............... : : : : : ( 80)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
139/156
133
.....
.....
/
( ) (
7-14 )
( ) (
)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
140/156
134
4.2 ...?4.2 ...?4.2 ...?4.2 ...?4.2 ...? 2550
1,433,230 1.3
38
/
( 99%)
-
8/12/2019 PCU Manual Phar and Cosumer Protection
141/156
135
4.3 ?4.3 ?4.3 ?4.3 ?4.3 ?
6
1. (1. 2.
3. 4.
5. )
2.
penicillin Co-amoxiclav, cephalosporins cloxacillin
-
8/12/2019 PCU Manual Phar and Cosumer Protection
142/156
136
-
( )
5. 5. 5. 5. 5.
-
8/12/2019 PCU Manual Phar and Cosumer Protection
143/156
137
www.thaidrugwatch.org 02-2188452
1.
. " " " " " " 28 . . 54 : http://www.kapookya.com
2. . ...
28 . . 54 : http://www.oryor.com/oryor/admin/module/fda_pub_leaflet/file/f_5_1252308200.pdf
3.
4 .11/2552 25 2552
4. Antibiotics Smart Use.
28 . . 54 : http://newsser.fda.
moph.go.th/rumthai/asu/download.php
-
8/12/2019 PCU Manual Phar and Cosumer Protection
144/156
138
16.1 . 30116.2
16.3 16.4 ( )
......16.5
14 :
-
8/12/2019 PCU Manual Phar and Cosumer Protection
145/156
139
1 6 . 1
. 3
0 1
-
8/12/2019 PCU Manual Phar and Cosumer Protection
146/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
147/156
141
2552, 2553 . .
()()()()()
( Visit) ( Visit) ( Visit) ( Visit) ( Visit)
25522553
53= (18914 - 17823) x 100 = 6.1% 17823
53= (397562 - 350423) x 100 = 13.4% 350423
17,82318,914
350,423397,562
-
8/12/2019 PCU Manual Phar and Cosumer Protection
148/156
142
1 6 . 3
-
8/12/2019 PCU Manual Phar and Cosumer Protection
149/156
143
-
8/12/2019 PCU Manual Phar and Cosumer Protection
150/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
151/156
145
1 6 . 5
-
8/12/2019 PCU Manual Phar and Cosumer Protection
152/156
-
8/12/2019 PCU Manual Phar and Cosumer Protection
153/156
147
9. ( )
1 .253210.
( ) . .253311.
( ) 253512.
( ,
) . .255313. 2552
2553(
)14. (
)
4 12 downlohttp://www.thaihealthconsumer.orghttp://www.thaihealthconsumer.orghttp://www.thaihealthconsumer.orghttp://www.thaihealthconsumer.orghttp://www.thaihealthconsumer.org 13-14 download www.thaidrugwatch.orgwww.thaidrugwatch.orgwww.thaidrugwatch.orgwww.thaidrugwatch.orgwww.thaidrugwatch.org
-
8/12/2019 PCU Manual Phar and Cosumer Protection
154/156
148
2321/2533
/
2553
1. .
2. .
3. .
4. .
-
8/12/2019 PCU Manual Phar and Cosumer Protection
155/156
149
5. .
6. .
7. . . .
8. . .
9. .
10. .
11. .
12. .
13. .
-
8/12/2019 PCU Manual Phar and Cosumer Protection
156/156
14. . .
1.
2.
3. 4.